检索结果-南通市图书馆

Inverted U-Shaped Associations between Glycemic Indices and Serum Uric Acid Levels in the General Chinese Population:Findings from the China Cardiometabolic Disease and Cancer Cohort(4C)Study

在线全文

学校读者我要写书评

暂无评论

Biomedical and Environmental Sciences 2021年第1期34卷 9-18页

作者： ZHU yuan yue ZHENG Rui Zhi WANG Gui Xia chen Li SHI Li Xin SU Qing XU min XU yu chen yu Hong yu Xue Feng yan Li WANG Tian Ge ZHAO Zhi yun QIN Gui jun WAN Qin chen Gang GAO Zheng Nan SHEN Fei Xia luO Zuo Jie QIN ying Fen HUO ya Nan LI Qiang YE Zhen ZHANG Yin Fei LIU Chao WANG You min WU sheng Li yanG Tao deNG hua Cong ZHAO Jia jun chen lu lu MU Yi ming TANG Xu Lei HU Ru ying WANG Wei Qing NING Guang LI Mian lu Jie Li BI yu Fang department of Endocrine and Metabolic Diseases Shanghai Institute of Endocrine and Metabolic DiseasesRuijin HospitalShanghai Jiao Tong University School of MedicineShanghai 200025China Shanghai National Clinical Research Center for Metabolic Diseases Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR ChinaShanghai National Center for Translational MedicineRuijin Hospital.Shanghai Jiao Tong UniversitySchool of MedicineShanghai 200025China The First Hospital of Jilin University Changchun 130021JinlinChina Qilu Hospital of Shandong University Jinan 250012ShandongChina Affiliated Hospital of Guiyang Medical College Guiyang 550004GuizhouChina Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai 200092China Tongji Hospital.Tongji Medical College Huazhong University of Science and TechnologyWuhan 430030HubeiChina Sun yat-sen Memorial Hospital Sun Yat-sen UniversityGuangzhou 510120GuangdongChina The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052HenanChina The Affiliated Hospital of Southwest Medical University Luzhou 646099SichuanChina Fujian Provincial Hospital Fujian Medical UniversityFuzhou 350001FujianChina Dalian Municipal Central Hospital Dalian 116003LiaoningChina The First Affiliated Hospital of Wenzhou Medical University Wenzhou 325000ZhejiangChina The First Affiliated Hospital of Guangxi Medical University Nanning 530021GuangxiChina Jiangxi Provincial People's Hospital Affiliated to Nanchang University Nanchang 330006JiangxiChina The Second Affiliated Hospital of Harbin Medical University Harbin 150086HeilongjiangChina Zhejiang Provincial Center for Disease Control and Prevention Hangzhou 310051ZhejiangChina Central Hospital of Shanghai Jiading District Shanghai 201800China Jiangsu Province Hospital on Integration of Chinese and Western Medicine Nanjing 210028JiangsuChina The First Affiliated Hospital of Anhui Medical University Hefei 230022AnhuiChina Karamay Municipal

Objective The relationship between serum uric acid(SUA)levels and glycemic indices,including plasma glucose(FPG),2-hour postload glucose(2 h-PG),and glycated hemoglobin(HbA1 c),remains *** aimed to explore the associations between glycemic indices and SUA levels in the general Chinese *** The current study was a cross-sectional analysis using the first follow-up survey data from The China Cardiometabolic Disease and Cancer Cohort Study.A total of 105,922 community-dwelling adults aged≥40 years underwent the oral glucose tolerance test and uric acid *** nonlinear relationships between glycemic indices and SUA levels were explored using generalized additive *** A total of 30,941 men and 62,361 women were eligible for the current *** additive models verified the inverted U-shaped association between glycemic indices and SUA levels,but with different inflection points in men and *** thresholds for FPG,2 h-PG,and HbA1 c for men and women were 6.5/8.0 mmol/L,11.0/14.0 mmol/L,and 6.1/6.5,respectively(SUA levels increased with increasing glycemic indices before the inflection points and then eventually decreased with further increases in the glycemic indices).Conclusion An inverted U-shaped association was observed between major glycemic indices and uric acid levels in both sexes,while the inflection points were reached earlier in men than in women.

关键词： Cross-sectional study Serum uric acid Glycemic index Glycemic status

Efficacy and safety of Shenyankangfu Tablet,a Chinese patent medicine,for primary glomerulonephritis:A multicenter randomized controlled trial

在线全文

学校读者我要写书评

暂无评论

Journal of Integrative Medicine 2021年第2期19卷 111-119页

作者： Jie Wu Shu-wei Duan Hong-tao yang yue-yi deng Wei Li ya-ni He Zhao-hui Ni Yong-li Zhan Shan Lin Zhi-yong Guo jun Zhu Jing-ai Fang Xu-sheng Liu Li-hua Wang Rong Wang Nian-song Wang Xiao-hong cheng Li-qun He Ping luo Shi-ren Sun Ji-feng Sun Ai-ping Yin Geng-ru Jiang Hong-yu chen Wen-hu Liu Hong-li Lin Meng Liang lu ma ming chen Li-qun Song Jian chen Qing Zhu Chang-ying Xing yun Li Ji-ning Gao Rong-shan Li ying Li Hao Zhang ying lu Qiao-ling Zhou jun-zhou Fu Qiang He Guang-yan Cai Xiang-mei chen department of Nephrology Chinese People’s Liberation Army General HospitalChinese People’s Liberation Army Institute of NephrologyState Key Laboratory of Kidney Diseases(2011DAV00088)National Clinical Research Center for Kidney DiseasesBeijing 100853China department of Nephrology First Teaching Hospital of Tianjin University of Traditional Chinese MedicineTianjin 300192China department of Nephrology Longhua HospitalShanghai University of Traditional Chinese MedicineShanghai 200032China department of Nephrology Shandong University of Traditional Chinese Medicine Affiliated HospitalJinan 250011.Shandong ProvinceChina department of Nephrology Daping HospitalArmy Medical UniversityChongqing 400042China department of Nephrology Renji HospitalShanghai Jiao Tong UniversityShanghai 200127China department of Nephrology Guang’anmen HospitalChina Academy of Traditional Chinese Medical SciencesBeijing 100053China department of Nephrology Tianjin Medical University General HospitalTianjin 300052China department of Nephrology Changhai Hospital of ShanghaiNaval Medical UniversityShanghai 200433China department of Nephrology West China HospitalChengdu 610083Sichuan ProvinceChina department of Nephrology First Affiliated Hospital of Shanxi Medical UniversityTaiyuan 030001Shanxi ProvinceChina department of Nephrology Guangdong Provincial Hospital of Chinese MedicineGuangzhou 510120Guangdong ProvinceChina department of Nephrology Shanxi Medical University Second Affiliated HospitalTaiyuan 030001Shanxi ProvinceChina department of Nephrology Shandong Provincial HospitalJinan 250021Shandong ProvinceChina department of Nephrology and Rheumatology Affiliated Sixth People’s HospitalShanghai Jiao Tong UniversityShanghai 200233China department of Nephrology Shaanxi Traditional Chinese Medicine HospitalXi'an 710003Shaanxi ProvinceChina department of Nephrology Shuguang HospitalShanghai University of Traditional Chinese MedicineShanghai 200021China department of Nephrology Jilin University Se

Background:Shenyankangfu Tablet(SYKFT)is a Chinese patent medicine that has been used widely to decrease proteinuria and the progression of chronic kidney ***:This trial compared the efficacy and safety of SYKFT,for the control of proteinuria in primary glomerulonephritis patients,against the standard drug,losartan ***,setting,participants and intervention:This was a multicenter,double-blind,randomized,controlled clinical *** glomerulonephritis patients,aged 18-70 years,with blood pressure≤140/90 mmHg,estimated glomerular filtration rate(eGFR)>45 mL/min per 1.73 ㎡,and 24-hour proteinuria level of 0.5-3.0 g,were recruited in 41 hospitals across 19 provinces in China and were randomly divided into five groups:SYKFT,losartan potassium 50 mg or 100 mg,SYKFT plus losartan potassium 50 mg or 100 *** outcome measu res:The primary outcome was change in the 24-hour proteinuria level,after 48 weeks of ***:A total of 735 participants were *** percent decline of urine protein quantification in the SYKFT group after 48 weeks was 8.78%±2.56%(P=0.006)more than that in the losartan 50 mg group,which was 0.51%±2.54%(P=1.000)less than that in the losartan 100 mg *** with the losartan potassium 50 mg group,the SYKFT plus losartan potassium 50 mg group had a 13.39%±2.49%(Plus losartan potassium 100 mg group had a 9.77%±2.52%(P=0.001)greater reduction in urine *** a superiority threshold of 15%,neither was statistically ***,serum creatinine and serum albumin from the baseline did not change statistically *** average change in TCM syndrome score between the patients who took SYKFT(-3.00[-6.00,-2.00])and who did not take SYKFT(-2.00[-5.00,0])was statistically significant(P=0.003).No obvious adverse reactions were observed in any ***:SYKFT decreased the proteinur

关键词： Herbal medicine,Chinese Shenyankangfu Tablet Primary glomerulonephritis Randomized controlled trial Double blind Double dummy

The In-Flight Realtime Trigger and Localization Software of GECAM

在线全文

学校读者我要写书评

暂无评论

Research in Astronomy and Astrophysics 2024年第10期24卷 11-24页

作者： Xiao-yun Zhao Shao-Lin Xiong Xiang-yang Wen Xin-Qiao Li Ce Cai Shuo Xiao Qi luo Wen-Xi Peng Dong-ya Guo Zheng-hua An Ke Gong Jin-yuan Liao yan-Qiu Zhang yue huang lu Li Xing Wen Fei Zhang Jing Duan chen-Wei Wang Dong-Li Shi Peng Zhang Qi-Bin Yi Chao-yang Li yan-Bing Xu Xiao-hua Liang ya-Qing Liu Da-Li Zhang Xi-Lei Sun Fan Zhang Gang chen huan-yu Wang sheng yang Xiao-Jing Liu min Gao mao-Shun Li Jin-Zhou Wang Xing Zhou Yi Zhao Wang-chen Xue Chao Zheng Jia-Cong Liu Xing-Bo Han Jin-Ling Qi Jia huang Ke-Ke Zhang Can chen Xiong-Tao yang Dong-Jie Hou yu-Sa Wang Rui Qiao Xiang ma Xiao-Bo Li Ping Wang Xin-ying Song Li-ming Song Shi-Jie Zheng Bing Li Hong-Mei Zhang yue Zhu Wei chen Jian-Jian He Zhen Zhang Jin Hou Hong-jun Wang yan-Chao Hao Xiang-yu Wang Zong-yuan yang Zhi-Long Wen Zhi Chang yuan-yuan Du Rui Gao Xiao-Fei Lan yan-Guo Li Gang Li Xu-Fang Li Fang-jun lu Hong lu Bin Meng Feng Shi Hui Wang Hui-Zhen Wang yu-Peng Xu Jia-Wei yang Xue-Juan yang Shuang-Nan Zhang Chao-yue Zhang cheng-Mo Zhang Zhi-cheng Tang cheng cheng Key Laboratory of Particle Astrophysics Institute of High Energy PhysicsChinese Academy of SciencesBeijing 100049China University of Chinese Academy of Sciences Chinese Academy of SciencesBeijing 100049China School of Information Science and Technology Southwest Jiaotong UniversityChengdu 611756China Key Laboratory of Stellar and Interstellar Physics and department of Physics Xiangtan UniversityXiangtan 411105China Physics and Space Science College China West Normal UniversityNanchong 637002China department of Astronomy Beijing Normal UniversityBeijing 100875China Innovation Academy for Microsatellites of CAS Shanghai 201203China Changchun University of Science and Technology Changchun 130022China Chinese Academy of Sciences South America Center for Astronomy National Astronomical ObservatoriesCASBeijing 100101China

Realtime trigger and localization of bursts are the key functions of GECAM,an all-sky gamma-ray monitor launched on 2020 december *** developed a multifunctional trigger and localization software operating in the CPU of the GECAM Electronic *** onboard software has the following features:high trigger efficiency for real celestial bursts with a suppression of false triggers caused by charged particle bursts and background fluctuation,dedicated localization algorithm optimized for both short and long bursts,and low time latency of the trigger information which is downlinked through the Global Short Message Communication service of the global BeiDou navigation *** paper provides a detailed description of the design and development of the trigger and localization software system for *** covers the general design,workflow,the main functions,and the algorithms used in the *** paper also includes on-ground trigger tests using simulated gamma-ray bursts generated by a dedicated X-ray tube,as well as an overview of the performance for real celestial bursts during its in-orbit operation.

关键词： telescopes instrumentation:detectors methods:observational

The first data release(DR1) of the LAMOST regular survey

在线全文

学校读者我要写书评

暂无评论

Research in Astronomy and Astrophysics 2015年第8期15卷 1095-1124页

作者： A-Li luo Yong-Heng Zhao Gang Zhao Li-Cai deng Xiao-Wei Liu Yi-Peng Jing Gang Wang Hao-Tong Zhang Jian-Rong Shi Xiang-Qun Cui yao-quan Chu Guo-Ping Li Zhong-Rui Bai yue Wu yan Cai Shu-yun Cao Zi-huang Cao Jeffrey L.Carlin Hai-yuan chen Jian-jun chen Kun-Xin chen Li chen Xue-Lei chen Xiao-yan chen ying chen Norbert Christlieb Jia-Ru Chu chen-Zhou Cui Yi-Qiao Dong Bing Du Dong-Wei Fan Lei Feng Jian-Ning Fu Peng Gao Xue-Fei Gong Bo-Zhong Gu yan-Xin Guo Zhan-Wen Han Bo-Liang He Jin-Liang Hou Yong-Hui Hou Wen Hou Hong-Zhuan Hu Ning-sheng Hu Zhong-Wen Hu Zhi-ying Huo Lei Jia Fang-hua Jiang Xiang Jiang Zhi-Bo Jiang Ge Jin Xiao Kong Xu Kong ya-Juan Lei Ai-hua Li Chang-hua Li Guang-Wei Li Hai-Ning Li Jian Li Qi Li Shuang Li Sha-Sha Li Xin-Nan Li yan Li Yin-Bi Li Ye-Ping Li yuan Liang Chien-cheng Lin Chao Liu Gen-Rong Liu Guan-Qun Liu Zhi-Gang Liu Wen-Zhi lu yu luo Yin-Dun mao Heidi Newberg Ji-jun Ni Zhao-Xiang Qi Yong-jun Qi Shi-Yin Shen Huo-ming Shi Jing Song Yi-Han Song Ding-Qiang Su Hong-jun Su Zheng-Hong Tang Qing-sheng Tao yuan Tian Dan Wang Da-Qi Wang Feng-Fei Wang Guo-min Wang Hai Wang Hong-Chi Wang Jian Wang Jia-Ning Wang Jian-Ling Wang Jian-Ping Wang jun-Xian Wang Lei Wang Meng-Xin Wang Shou-Guan Wang Shu-Qing Wang Xia Wang ya-Nan Wang You Wang yue-Fei Wang You-Fen Wang Peng Wei ming-Zhi Wei Hong Wu Ke-Fei Wu Xue-Bing Wu yu-Zhong Wu Xiao-Zheng Xing Ling-Zhe Xu Xin-Qi Xu yan Xu Tai-sheng yan de-hua yang Hai-Feng yang Hui-Qin yang ming yang Zheng-Qiu yao Yong yu Hui yuan Hai-Bo yuan Hai-Long yuan Wei-min yuan Chao Zhai En-Peng Zhang hua-Wei Zhang Jian-Nan Zhang Li-Pin Zhang Wei Zhang Yong Zhang yan-Xia Zhang Zheng-Chao Zhang ming Zhao Fang Zhou Xu Zhou Jie Zhu Yong-Tian Zhu Si-cheng Zou Fang Zuo National Astronomical Observatories Chinese Academy of Sciences department of Astronomy Peking University Shanghai Astronomical Observatory Chinese Academy of Sciences Nanjing Institute of Astronomical Optics & Technology National Astronomical ObservatoriesChinese Academy of Sciences University of Science and Technology of China department of Physics Applied Physics and AstronomyRensselaer Polytechnic InstituteTroyNY 12180USA department of Physics and Astronomy Earlham CollegeRichmondIN 47374USA Universitt Heidelberg Zentrum für AstronomieLandessternwarteKnigstuhl 1269117 HeidelbergGermany department of Astronomy Beijing Normal University yunnan Observatories Chinese Academy of Sciences Purple Mountain Observatory Chinese Academy of Sciences

The Large sky Area Multi-Object Fiber Spectroscopic Telescope（LAMOST） general survey is a spectroscopic survey that will eventually cover approximately half of the celestial sphere and collect 10 million spectra of stars, galaxies and QSOs. Objects in both the pilot survey and the first year regular survey are included in the LAMOST DR1. The pilot survey started in October 2011 and ended in june 2012, and the data have been released to the public as the LAMOST Pilot Data Release in August 2012. The regular survey started in September 2012, and completed its first year of operation in june 2013. The LAMOST DR1 includes a total of 1202 plates containing 2 955 336 spectra, of which 1 790 879 spectra have observed signalto-noise ratio（SNR） ≥ 10. All data with SNR ≥ 2 are formally released as LAMOST DR1 under the LAMOST data policy. This data release contains a total of 2 204 696 spectra, of which 1 944 329 are stellar spectra, 12 082 are galaxy spectra and 5017 are quasars. The DR1 not only includes spectra, but also three stellar catalogs with measured parameters： late A,FGK-type stars with high quality spectra（1 061 918 entries）, A-type stars（100 073 entries）, and M-type stars（121 522 entries）. This paper introduces the survey design, the observational and instrumental limitations, data reduction and analysis, and some caveats. A description of the FITS structure of spectral files and parameter catalogs is also provided.

关键词： techniques: spectroscopic survey—data release—catalog

Consensus statement on layout and delivery of automatic external defibrillator in China

在线全文

学校读者我要写书评

暂无评论

Journal of Hainan Medical University 2020年第15期26卷 18-23页

作者： yu Cao Song chen yan-Fen Chai Xiao-Hui chen yu-Guo chen Shao-Wen cheng Wen-Wei cheng Bang-Han Ding yang deng Jie Fu Bang-Jiang Fang mai-ying Fan Li Gui Ping Gong Wei Guo Shu-Bin Guo Liang huang Ji-yuan Han Zhong Ji Xian-Fei Ji Xin-Cai Ji Hong-Xu Jin Xin-jun Jiang Wang-Xiang Jiang Jia-Liang Liu Xiao-Ran Liu Zhi Liu Chuan-Zhu Lv Feng lu Tan-Shi Li Xin Li Yong Li Shang-lun Li Shuang-ming Li Xiao-Gang Li Bao-jun Li Pei-Wu Li Chun-sheng Li Zhi-jun Li Chang-luo Li Xiang-min Li Yin-Ping Li Zong-jun lu Zu-Xun lu Zhong-Qiu lu Zhi-Qian luo Xiao-Xing Liao Jian-Bo Lei Tao ma yu ma yue-Feng ma Qing-Bian ma Lin-Hao ma jun-Qi ma Shi-Nan Nie Jie-Miao Ou-yang Peng Peng Qiao Pei Shu-ming Pan Guo-Zhong Qing Li-Jie Qin Wu-ying Qiao Fei Shao Wei Song Xing-yue Song Zhen-Ju Song Rong-Ju Sun de-ya Shang Du-Juan Sha Gui-Lan Tao Guo-Gang Tian ying-Ping Tian Jian-Guang Tian Chao-yang Tong Zi-Ren Tang Meng-Xiong Tang Guo-Ping Wu Zhi Wan Tao Wang Xin Wang Peng Wang Zhong Wang Tong Wang Ri-Xing Wang Yi-Xin Wang Xiao-Dan Wang Ling Wu Wei Wei hua Xiang Feng Xu jun Xu Jie Xu Miao-Rong Xie Shuo-Gui Xu Tie Xu Feng yu Wen Yi Li-Shan yang Shi-Jiao yan Jin-Jian yao Shou-Chun yan Xue-Zhong yu Xian-Zhi Ye Xian-Liang yan Fu-Bing Zhou Rong-Bin Zhou ming Zhou Qiang Zhou Jin Zhou Ping Zhou Chang-Ju Zhu hua-Dong Zhu Ji-Hong Zhu Hong Zhang mao Zhang hua Zhang Na Zhang Guo-Qiang Zhang Guo-Xiu Zhang Jin-Song Zhang Wen-Wu Zhang Wen-Zhong Zhang Jian-Feng Zhang Yi-min Zhu jun Zeng yuan Zheng Zhi-Jie Zheng Shen Zhao yan Zhao min Zhao Bin Zhao Xiao-Dong Zhao Xiao-Jing Zhao Hong-Ke Zeng sheng-Qiang Zou The Chinese Society of Emergency Medicine Research Unit of Island Emergency Medicine Chinese Academy of Medical SciencesHainan Medical University Key Laboratory of Emergency and Trauma of ministry of Education Hainan Medical UniversityHaikouHainanChina Emergency and Trauma College Hainan Medical UniversityHaikouHainanChina department of Emergency Hainan Clinical Research Center for Acute and Critical DiseasesThe Second Affiliated Hospital of Hainan Medical UniversityHaikouHainanChina Key Laboratory of Hainan Trauma and Disaster Rescue Key Laboratory of Trauma of Hainan Medical University

*** Sudden cardiac death(SCD)refers to sudden death due to a variety of cardiac *** is manifested as a sudden loss of consciousness,cardiac arrest,and respiratory arrest and generally shows early symptoms that are atypical and not easily detected[1].According to a recent study,nearly 544000 patients suffer from SCD every year in China[2].

关键词： cardiac death respiratory

2018 Chinese Guidelines for Prevention and Treatment of Hypertension——A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Journal of Geriatric Cardiology 2019年第3期16卷 182-241页

作者： Joint Committee for Guideline Revision Chinese Hypertension League Chinese Society of Cardiology Hypertension Committee of the Chinese Medical Doctor Association Hypertension Branch of the China Association for the Promotion of International Exchanges of Health Care Hypertension Branch of the Chinese Geriatrics Society Li–sheng LIU Chinese Hypertension LeagueChinese Society of CardiologyHypertension Committee of the Chinese Medical Doctor AssociationHypertension Branch of the China Association for the Promotion of International Exchanges of Health CareHypertension Branch of the Chinese Geriatrics SocietyRevision Committee MembersChair: Li-sheng LIU[*]deputy Chairs: Zhao-Su WU Ji-Guang WANG Wen WANGMembers (Listed in alphabetic order by last name in Chinese Pinyin)Yu-Jing BAO Jun CAI Lu-Yuan CHEN Wei-Wei CHEN Shao-Li CHU Ying-Qing FENG Ping-Jin GAO Ting-Rui GUAN Zi-Hong GUO Qi HUA Jun HUANG Yong HUO Wei-Ping JIA Xiong-Jing JIANG Yi-Nong JIANG Li LI Li-Huan LI Nan-Fang LI Wei LI Xiao-Ying LI Xue-Wang LI Yan LI Yong LI Jin-Xiu LIN Li-Sheng LIU Xin-Zheng LU Ji-Xiang MA Jie MI Jian-Jun MU Chang-Yu PAN Gang SUN Ning-Ling SUN Ying-Xian SUN Jun TAO Hao WANG Ji-Guang WANG Wen WANG Wen-Zhi WANG Yong-Jun WANG Yu WANG Zeng-Wu WANG Hai-Ying WU Zhao-Su WU Liang-Di XIE Zhang-Rong XU Xiao-Wei YAN Yan-Min YANG Chong-Hua YAO Zheng-Pei ZENG Jian ZHANG Wei-Zhong ZHANG Xin-Hua ZHANG Xin-Jun ZHANG Yu-Qing ZHANG Ding-Liang ZHU Jun ZHU Zhi-Ming ZHUScientific Committee MembersXiang-Mei CHEN Hong CHEN Jun-Shi CHEN Xiao-Ping CHEN Yun-Dai CHEN Zhao-Qiang CUI Xue-Ping DU Li FAN Run-Lin GAO Jun-Bo GE Luo-Bu GE-SANG Dong-Feng GU Jing-Xuan GUO Yi-Fang GUO Qing-Hua HAN Ya-Ling HAN Zhao-Guang HONG Da-Yi HU Jian-Ping LI Guang-Wei LI Guang-Ping LI Xin-Li LI Yu-Ming LI Xiao-Feng LIANG Yi-Shi LI Yu-Hua LIAO Shu-Guang LIN Mei-Lin LIU Jing LIU Wei LIU Fang-Hong LU Shu-Ping MA Qian-Hui SHANG Yi-Pu CHEN Hai-Qin Tang Xin-Hua TANG Gang TIAN Ke-An WANG Xing-Yu WANG Dao-Wen WANG Shou-Ling WU Cheng-Bin XU Shou-Chun XU Xin-Juan XU Xin-Hua YIN Bo YU Guo-Ying YU Jing YU Wei YU Meng-Sun YU Hong YUAN Ru-Yu YUAN Chun-Yu ZENG Zhe-Chun ZENG Lin ZHANG Hui-Min ZHANG Dong ZHAO Luo-Sha ZHAO Lian-You ZHAO Xiao-Fang ZHOU Man-Lu ZHU*Correspondence to:moc.621@lhcsll (LIU LS)

Table of Contents Preamble 1 Prevalence of hypertension in Chinese population 1.1 Prevalence,incidence and epidemic trend of hypertension in Chinese population 1.2 Awareness,treatment and control of Hypertension in China 1.3 Important risk factors for hypertension in Chinese population 2 Hypertension and cardiovascular risk 2.1 Relationship between blood pressure and cardiovascular risk 2.2 Cardiovascular risk characteristics of hypertension population in China 3 Diagnostic evaluation 3.1 Medical history 3.2 Physical examination 3.3 Laboratory examinations 3.4 Genetic analysis 3.5 BP measurement 3.6 Evaluation of target organ damage.

关键词： 2018 Chinese Guidelines Contents Preamble Prevention and Treatment

2017年中国ICU患者营养治疗实施状况横断面调查

在线全文

学校读者我要写书评

暂无评论

解放军医学杂志 2019年第5期44卷 388-393页

作者：邢娟章仲恒柯路周晶秦秉玉梁宏开陈晓梅刘文明刘忠民艾宇航王迪芬王秋卉周青山张福森钱克俭蒋东坡臧彬黎毅敏黄晓波曲彦谢颖光许东琳邹志强郑祥德刘建波郭丰梁亚风孙强高红梅刘阳常平程爱斌杨荣利么改琦孙昀王晓蓉张怡熊旭明于健孙荣青李志伟袁世荧宋云林高培阳刘海燕张朝辉吴允孚马标郭强山峰杨明施李海玲李圆菲鲁卫华王磊钱传云王智勇林建东张汝敏万鹏彭志勇龚裕强黄林喜伍国宝孙洁邓义军师东武周立新周发春石秦东郭晓东刘雪燕武卫东孟祥忠李连弟陈炜炜李树生万献尧曹志新张安古利明陈炜吴京兰周丽华张震环翁以炳封永顺杨春丽冯永健赵素民佟飞郝东韩辉付宝才巩传勇李志平胡琨琳寇秋野张晗刘洁樊楚明周新陈秀梅孙俊丽周学军宋斌孙诚赵丽芸董兴鲁张琳琳佟大为潘志国蔡常洁王东浩董英俊龚园其吴志松孟新科王平李维勤南京医科大学金陵临床医学院南京210002 无锡人民医院江苏无锡214001 北京市密云区医院北京101500 洛阳市中心医院河南洛阳471009 北京市怀柔区第一医院北京101400 陆军总医院北京100700 广东省人民医院广州510080 广东省第二中医院广州510095 北京中医医院北京100010 安徽省立医院西院区合肥230001 沈阳市第一人民医院沈阳110041 南部战区总医院广州510050 湖北省人民医院武汉430060 中山大学附属第一医院广州510080 天津市肿瘤医院天津300060 山西省肿瘤医院太原030000 南昌大学第二附属医院南昌330006 北京中医药大学东方医院北京100029 深圳第二人民医院广东深圳100730 成都市第五人民医院成都611130 泰安市中心医院山东泰安271000 南昌大学第一附属医院南昌330006 陆军军医大学大坪医院重庆400042 中国医科大学附属第二医院沈阳110004 广州医科大学附属第一医院广州510120 四川省人民医院成都610072 青岛市立医院青岛266071 济宁市第一人民医院山东济宁272000 浙江大学医学院附属邵逸夫医院杭州310016 广州市第一人民医院广州510000 福建医科大学附属协和医院福州350001 达州市中心医院四川达州635000 内蒙古自治区人民医院呼和浩特010017 烟台毓璜顶医院山东烟台264000 天津市人民医院天津300000 天津市第一中心医院天津300192 唐山市工人医院河北唐山063000 南方医科大学珠江医院广州510515 华北理工大学附属医院河北唐山063210 河南省人民医院郑州450003 大连市中心医院辽宁大连116033 北京大学第三医院北京100083 安徽医科大学第二附属医院合肥230601 温州医科大学附属第一医院浙江温州325000 陕西省人民医院西安710068 广州医科大学附属第二医院广州510120 大连医科大学附属第二医院辽宁大连116011 郑州大学第一附属医院郑州450052 昆明市第一人民医院昆明650011 华中科技大学同济医学院附属协和医院武汉430030 中山市人民医院广东中山528403 新疆医科大学第一附属医院乌鲁木齐830054 成都中医药大学附属医院成都610075 安徽医科大学第一附属医院合肥230032 宜昌市中心人民医院湖北宜昌443003 苏州市立医院东区江苏苏州215008 济宁医学院附属医院山东济宁272000 苏州大学附属第一人民医院江苏苏州215006 青岛大学医学院附属医院东院区山东青岛266071 中南大学湘雅三医院长沙410013 海军第971医院山东青岛266073 山东大学齐鲁医院济南250012 长沙市中心医院长沙410000 皖南医学院弋矶山医院安徽芜湖241002 山西医科大学第一医院太原030001 昆明医科大学第一附属医院昆明650032 河北医科大学第三医院石家庄050017 福建医科大学附属第一医院福州350004 淄博市中心医院山东淄博100085 宜昌市第一人民医院湖北宜昌443003 武汉大学中南医院武汉430071 温州医科大学附属第二医院浙江温州325035 常州市第二人民医院江苏常州213003 汕头大学医学院第一附属医院广东汕头515041 中南大学湘雅二医院长沙410013 云南省第二人民医院昆明650021 盐城市第一人民医院江苏盐城224006 山西省人民医院太原030012 佛山市第一人民医院广东佛山528000 重庆医科大学附属第一医院重庆400016 西安交通大学第一附属医院西安710061 解放军总医院第三医学中心北京100039 深圳市人民医院广东深圳518001 吉林大学第一医院长春130031 山西医学科学院山西大医院太原030032 解放军第254医院天津300142 青岛大学附属医院山东青岛266003 临海市第一人民医院浙江台州317000 华中科技大学同济医学院附属同济医院武汉430030 大连医科大学附属第一医院辽宁大连116011 北京朝阳医院京西院区北京100043 重庆医科大学附属第二医院重庆400016 玉溪市人民医院云南玉溪653405 首都医科大学世纪坛医院北京100036 中南大学湘雅医院长沙410013 深圳市南山人民医院广东深圳518067 内蒙古医科大学附属医院呼和浩特010050 南京明基医院南京210019 首都医科大学附属北京潞河医院北京101149 京煤集团总医院北京102300 江西省人民医院南昌330006 暨南大学附属第一医院广

目的了解国内ICU收治患者的营养治疗实施状况。方法对国内116家医院的118个ICU内的患者进行营养治疗实施状况的横断面调查。以2017年4月26日0时所有在ICU内治疗的患者为调查对象,收集患者基本信息、2017年4月25日(即调查日)的营养实施... 详细信息

目的了解国内ICU收治患者的营养治疗实施状况。方法对国内116家医院的118个ICU内的患者进行营养治疗实施状况的横断面调查。以2017年4月26日0时所有在ICU内治疗的患者为调查对象,收集患者基本信息、2017年4月25日(即调查日)的营养实施和胃肠道耐受情况,以及患者的28 d临床转归情况。结果调查共收集病例1953例,女631例(32.4%),男1306例(66.9%),缺失16例(0.7%);年龄(64.1±19.3)岁(1950例)。患者GCS、SOFA和APACHEⅡ评分分别为(10.76±4.35)分(1749例)、(5.65±3.52)分(1783例)、(17.14±7.31)分(1792例)。28 d临床转归存活1483例(75.9%),死亡312例(16.0%),失访+缺失158例(8.1%)。除身高和体重(P=0.000)外,男性与女性患者在年龄、病情严重程度及28 d临床转归等方面差异均无统计学意义。1953例患者中,胃肠功能评估为正常或轻度损害占73.7%(1440例),中-重度损害占10.8%(210例),衰竭占1.7%(33例),13.2%(258例)的患者未做评估。截至调查日,69.4%(1356例)的患者已启动肠内营养(EN),36.4%(711例)的患者已启动肠外营养(PN)。调查日有营养摄入的患者1720例(88.1%)。1953例患者中明确有恶心、呕吐反流、误吸、腹痛、腹胀、腹泻(大便次数≥3次/d且量≥500 ml/d)等胃肠道不耐受表现的分别占总人数的4.8%(93例)、5.4%(105例)、0.9%(17例)、8.7%(170例)、27.5%(538例)和4.3%(84例)。在1270例使用EN的病例中,明确存在恶心、呕吐反流、误吸、腹痛、腹胀、腹泻等不耐受症状的分别占3.2%(40例)、4.3%(54例)、0.8%(10例)、4.4%(56例)、26.9%(341例)和5.4%(69例)。入ICU后24 h内开始EN治疗的患者占22.4%(437/1953),48 h内开始的占38.6%(754/1953),72 h内开始的占46.6%(911/1953)。患者入ICU后3 d总热卡(EN+PN非蛋白热卡)达标率为12.9%(78/607),7 d总热卡达标率为18.7%(189/1010),14 d总热卡的达标率为23.0%(305/1325)。入ICU后3、7、14 deN达标率分别为9.9%(60/607)、15.0%(151/1010)和18.6%(246/1325)。结论目前我国ICU内的绝大多数患者均接受了营养治疗,其中EN的使用率明显高于PN;但EN的开始时间和达标情况仍不理想,且实施营养治疗时未能体现个体化差异,营养治疗的细节仍需要提高。

关键词：横断面研究肠内营养重症监护病房胃肠道耐受性营养达标率

在线全文

学校读者我要写书评

暂无评论

早期肺癌围术期治疗专家共识

循证医学 2019年第4期19卷 193-198页

作者：无吴一龙陆舜王长利王俊程颖陈晓媛陈明王群范云揣少坤汪笑男张力杨跃杨帆王洁陈海泉支修益胡成平杨衿记刘宏旭蔡开灿张绪超刘永煜黄诚许林毛伟敏周清华康晓征李强张兰军周建娅黄云超汪步海邬麟徐松涛钟文昭徐世东杨农朱正飞林冬梅廖日强宋启斌杨林刘再毅蔡修宇蒋峰胡毅陈元马智勇乔贵宾宋勇林根赵明芳周清卢铀闫小龙王志杰刘晓晴马海涛彭忠民岳东升施巍炜廖美琳管忠震陈婧华中国临床肿瘤学会、中国抗癌协会肺癌专业委员会广州燃石医学检验有限公司广州510300 南京世和基因生物技术有限公司南京210032 中山大学肿瘤防治中心广州510060 北京大学肿瘤医院北京100142 中国医学科学院肿瘤医院北京100021 复旦大学附属肿瘤医院上海200032 首都医科大学宣武医院北京100053 中南大学湘雅医院长沙410008 中国医科大学肿瘤医院沈阳110042 南方医科大学南方医院广州510515 广东省人民医院、广东省医学科学院、广东省肺癌研究所广州510080 沈阳市第十人民医院沈阳110044 福建省肿瘤医院福州350014 江苏省肿瘤医院南京210009 四川大学华西医院成都610041 四川省肿瘤医院成都610041 浙江大学附属第一医院杭州310003 云南省肿瘤医院昆明650118 苏北人民医院江苏扬州225001 湖南省肿瘤医院长沙410013 哈尔滨医科大学附属肿瘤医院哈尔滨150081 上海交通大学附属胸科医院上海200030 武汉大学人民医院武汉430060 深圳市人民医院广东深圳518020 解放军总医院第一医学中心北京100853 华中科技大学同济医学院附属同济医院武汉430030 河南省肿瘤医院郑州450003 东部战区总医院南京210002 中国医科大学附属第一医院沈阳110001 空军军医大学唐都医院西安710038 解放军总医院第五医学中心北京100071 苏州大学附属第一医院江苏苏州215006 天津医科大学肿瘤医院天津300060 山东省立医院济南250021 至本医疗科技(上海)有限公司上海201114 北京大学人民医院北京100044 吉林省肿瘤医院长春130021 国家食品药品监督管理总局药品审评中心北京100038 浙江省肿瘤医院杭州310022 复旦大学附属中山医院上海200032

由中国临床肿瘤学会和中国抗癌协会肺癌专业委员会主办,中国胸部肿瘤研究协作组、广东省抗癌协会肺癌专业委员会、广东省医学科学院、广东省人民医院和广东省肺癌研究所承办的第16届中国肺癌高峰论坛于2019年3月1-2日在广州召开。此次... 详细信息

由中国临床肿瘤学会和中国抗癌协会肺癌专业委员会主办,中国胸部肿瘤研究协作组、广东省抗癌协会肺癌专业委员会、广东省医学科学院、广东省人民医院和广东省肺癌研究所承办的第16届中国肺癌高峰论坛于2019年3月1-2日在广州召开。此次论坛从早期肺癌围手术期治疗的实践、探索、展望、共识四个角度开展相关学术探讨,达成了专家共识。

关键词：早期肺癌围术期治疗循证医学共识

在线全文

学校读者我要写书评

暂无评论

免疫治疗:在混沌与曙光中探索

循证医学 2017年第4期17卷 193-198页

作者：无吴一龙王长利廖美琳管忠震高晨燕陆舜赵明芳王洁刘晓晴杨衿记梁军毛伟敏韩宝惠张绪超宋勇冯继锋马胜林伍钢周彩存陈克能程颖何勇陈椿王群林基祯朱波刘云鹏胡毅乔贵宾周清宋启斌吴楠邬麟黄诚傅小龙熊建萍胡洁胡成平常建华赵琼赵军周鹏辉马智勇陈元张贺龙杨帆王建军潘跃银杨学宁范云刘喆樊旼杨农管彦芳孙浩钟文昭广东省人民医院、广东省医学科学院、广东省肺癌研究所广州510080 天津医科大学附属肿瘤医院天津300060 上海交通大学附属胸科医院上海200030 中山大学附属肿瘤医院广州510060 国家食品药品监督管理局药品审评中心北京100038 中国医科大学附属第一医院沈阳110001 中国医学科学院肿瘤医院北京100021 中国人民解放军307医院北京100071 北京大学国际医院北京102206 浙江省肿瘤医院杭州310022 南京军区南京总医院南京210002 江苏省肿瘤医院南京210009 杭州市第一人民医院杭州310006 华中科技大学同济医学院附属协和医院武汉430022 同济大学附属上海市肺科医院上海200433 北京大学临床肿瘤学院北京100036 吉林省肿瘤医院长春130021 第三军医大学大坪医院重庆400042 福建医科大学附属协和医院福州350001 复旦大学附属中山医院上海200032 福建医科大学福州350122 第三军医大学新桥医院重庆400037 中国人民解放军总医院北京100853 广州军区广州总医院广州510010 武汉大学人民医院武汉430060 湖南省肿瘤医院长沙410013 福建省肿瘤医院福州350014 南昌大学第一附属医院南昌330006 中南大学湘雅医院长沙410008 复旦大学附属肿瘤医院上海200032 浙江大学附属第一医院杭州310003 河南省肿瘤医院郑州450003 华中科技大学同济医学院附属同济医院武汉430030 第四军医大学唐都医院西安710038 北京大学人民医院北京100044 安徽医科大学第一附属医院合肥230022 首都医科大学附属北京胸科医院北京101149 北京吉因加科技有限公司北京102206 中国临床肿瘤学会中国抗癌协会肺癌专业委员会

2017年3月3-4日，中国临床肿瘤学会（Chinese Society of Clinical Oncology，CSCO）和中国抗癌协会肺癌专业委员会联合主办了第十四届“中国肺癌高峰论坛”。本次论坛的主题是“精准与联合：共谱免疫治疗新乐章”。检查点抑制剂（Check... 详细信息

2017年3月3-4日，中国临床肿瘤学会（Chinese Society of Clinical Oncology，CSCO）和中国抗癌协会肺癌专业委员会联合主办了第十四届“中国肺癌高峰论坛”。本次论坛的主题是“精准与联合：共谱免疫治疗新乐章”。检查点抑制剂（Checkpoint inhibitor）因其对多肿瘤类别广泛的适用性及能带来持久的有效缓解，短期内在全球范围掀起了免疫治疗的狂潮。而在非小细胞肺癌患者中，免疫治疗同样带来了令人欣喜的临床获益。

关键词：肺肿瘤免疫治疗循证医学共识